These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3260160)

  • 1. Treatment of experimental myasthenia gravis with total lymphoid irradiation.
    de Silva S; Blum JE; McIntosh KR; Order S; Drachman DB
    Clin Immunol Immunopathol; 1988 Jul; 48(1):31-41. PubMed ID: 3260160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total lymphoid irradiation and antigen-specific tolerance: future therapy for experimental myasthenia gravis?
    de Silva S; McIntosh K; Blum JE; Order S; Mellits D; Drachman DB
    J Neuroimmunol; 1990; 29(1-3):93-103. PubMed ID: 1698818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Qiao J; Olsson T; Huang WX
    J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined short-term immunotherapy for experimental autoimmune myasthenia gravis.
    Pestronk A; Drachman DB; Teoh R; Adams RN
    Ann Neurol; 1983 Aug; 14(2):235-41. PubMed ID: 6354071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX; Ma CG; Xiao BG; Bakhiet M; Link H; Olsson T
    Eur J Immunol; 1995 May; 25(5):1191-8. PubMed ID: 7774622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Huang J; Olsson T; He B; Link H
    J Neurol Sci; 1995 Feb; 128(2):167-74. PubMed ID: 7537794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY; Qiao J; Link H
    J Neuroimmunol; 1993 May; 44(2):209-14. PubMed ID: 8505410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S; McIntosh K; Drachman DB
    Ann Neurol; 1994 Nov; 36(5):704-13. PubMed ID: 7979216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental myasthenia gravis with cyclosporin A.
    Drachman DB; Adams RN; McIntosh K; Pestronk A
    Clin Immunol Immunopathol; 1985 Feb; 34(2):174-88. PubMed ID: 3871377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor.
    Ma CG; Zhang GX; Xiao BG; Link J; Olsson T; Link H
    J Neuroimmunol; 1995 Apr; 58(1):51-60. PubMed ID: 7537280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD; Bai XF; Li HL; Huang YM; Van der Meide PH; Link H
    Clin Exp Immunol; 1998 Mar; 111(3):506-12. PubMed ID: 9528890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide.
    Pestronk A; Drachman DB; Adams RN
    Muscle Nerve; 1982 Jan; 5(1):79-84. PubMed ID: 6977088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis.
    McIntosh KR; Drachman DB
    Science; 1986 Apr; 232(4748):401-3. PubMed ID: 2938256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.